0000899243-18-025551.txt : 20180928 0000899243-18-025551.hdr.sgml : 20180928 20180928204333 ACCESSION NUMBER: 0000899243-18-025551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180926 FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cassidy Sean A CENTRAL INDEX KEY: 0001421914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38672 FILM NUMBER: 181095651 MAIL ADDRESS: STREET 1: 322 EAST MAIN STREET CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC CENTRAL INDEX KEY: 0001655759 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472566120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 WINCHESTER COMPANY, LLC STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-535-1456 MAIL ADDRESS: STREET 1: 395 WINCHESTER COMPANY, LLC STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-26 0 0001655759 ARVINAS HOLDING COMPANY, LLC ARVN 0001421914 Cassidy Sean A C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE. NEW HAVEN CT 06511 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 16.00 2018-09-26 4 A 0 1980 0.00 A 2028-09-25 Common Stock 1980 1980 D Stock Option (right to buy) 16.00 2018-09-26 4 A 0 31710 0.00 A 2028-09-25 Common Stock 31710 31710 D Stock Option (right to buy) 16.00 2018-09-26 4 A 0 15160 0.00 A 2028-09-25 Common Stock 15160 15160 D Stock Option (right to buy) 16.00 2018-09-26 4 A 0 5200 0.00 A 2028-09-25 Common Stock 5200 5200 D Stock Option (right to buy) 16.00 2018-09-26 4 A 0 81770 0.00 A 2028-09-25 Common Stock 81770 81770 D Stock Option (right to buy) 16.00 2018-09-26 4 A 0 27330 0.00 A 2028-09-25 Common Stock 27330 27330 D This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. /s/ Matthew Batters, as attorney-in-fact for Sean A Cassidy 2018-09-28